Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. S. Song, H. K. Yoon, Y. K. Kim, H. S. Moon, S. H. Park (Seoul, Republic Of Korea). Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis. Eur Respir J 2008; 32: Suppl. 52, 3485

Member's Comments

No comment yet.

Related content which might interest you: The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 20: Suppl. 38, 487s Year: 2002 A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice Source: Eur Respir J 2012; 40: 1475-1482 Year: 2012 HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside Year: 2012 Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 461s Year: 2005 PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 PAR-2 antagonist inhibits bleomycin-induced lung fibrosis. Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia Year: 2021 Effect of NF-?B inhibitor IMD-1041 on BLM-induced pulmonary fibrosis in mice Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 Upregulation of Fas-signalling molecules in lung epithelial cells from patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 17: 180-189 Year: 2001 Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001 Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis Source: Eur Respir J 2007; 30: 205-213 Year: 2007 Bleomycin induces cellular senescence in alveolar epithelial cells Source: Eur Respir J 2003; 22: 436-443 Year: 2003 Simvastatin attenuates cigarette-smoke- induced emphysema and promotion of alveolar epithelial cell proliferation in rats Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Inhibition of pulmonary collagen-I, III and fibrotic cytokins in bleomycin induced pulmonary fibrosis by okam J201 Source: Eur Respir J 2005; 26: Suppl. 49, 81s Year: 2005 NADPH oxidase 4 deficiency protects from bleomycin-induced epithelial cell death and pulmonary fibrosis Source: Annual Congress 2010 - New insights into reactive oxygen species Year: 2010 Potential role of cathepsin S in bleomycin-induced lung fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 729s Year: 2005 Bromodomain inhibitor JQ1 attenuates TGF-beta-suppressed SOD2 expression and reduces proliferation in human primary pulmonary fibroblasts Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013